Growth Metrics

Vivos Therapeutics (VVOS) Treasury Shares (2026)

Vivos Therapeutics (VVOS) reported Treasury Shares of $1.8 million for Q1 2026.

Vivos Therapeutics (VVOS) has 1 years of Treasury Shares data on file, last reported at $1.8 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 256.42 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 263.29 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 7.51 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 2.12 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 325.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 900,000.00
10 Vivos Therapeutics 9.87 Mn 7.64 Mn 3.06 Mn 1.78 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.78 Mn
Mar 31, 2026 1.78 Mn